{"nct_id":"NCT04191135","title":"Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2019-12-19","start_date_type":"ACTUAL","primary_completion_date":"2022-12-15","primary_completion_date_type":"ACTUAL","completion_date":"2025-11-18","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}